Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Northern Drug/Krelitz

Executive Summary

Northern Drug company will pay an estimated $4 mil.-$5 mil. to acquire the Minneapolis wholesaler under an agreement in principle announced June 18. Privately held Northern Drug of Duluth, Minn. is controlled by the Goldfine family and has annual sales of approximately $50 mil. to 250 accounts. Krelitz had nine-month sales of $161.5 mil. in the period ended Jan. 31, down from $187 mil. in the same period the year before. The wholesaler lost a major account with the Voluntary Hospitals of America in November 1992. The merger is subject to approval by Krelitz shareholders; the Krelitz family controls more than 50% of the stock.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS022860

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel